A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Recruiting

Phase 1

MQ710A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05859074

Conditions

Cutaneous Squamous Cell Carcinoma

SCC - Squamous Cell Carcinoma

Basal Cell Carcinoma

BCC

BCC - Basal Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MQ719

Pembrolizumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-12. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-12-03.